Lorraine Spector

Array ( [id] => 1457769 [patent_doc_number] => 06391311 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1' [patent_app_type] => B1 [patent_app_number] => 09/040220 [patent_app_country] => US [patent_app_date] => 1998-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16160 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/391/06391311.pdf [firstpage_image] =>[orig_patent_app_number] => 09040220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4286541 [patent_doc_number] => 06180107 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-30 [patent_title] => 'Vascular endothelial cell growth factor II' [patent_app_type] => 1 [patent_app_number] => 9/038199 [patent_app_country] => US [patent_app_date] => 1998-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 54 [patent_no_of_words] => 12963 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/180/06180107.pdf [firstpage_image] =>[orig_patent_app_number] => 038199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7078984 [patent_doc_number] => 20010041668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-15 [patent_title] => 'METHODS FOR MODULATING HEMATOPOIESIS AND VASCULAR GROWTH' [patent_app_type] => new [patent_app_number] => 09/021660 [patent_app_country] => US [patent_app_date] => 1998-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 18026 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20010041668.pdf [firstpage_image] =>[orig_patent_app_number] => 09021660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4353748 [patent_doc_number] => 06254870 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-03 [patent_title] => 'Thrombopoietin: IL-3 fusion protein' [patent_app_type] => 1 [patent_app_number] => 8/875533 [patent_app_country] => US [patent_app_date] => 1998-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36833 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/254/06254870.pdf [firstpage_image] =>[orig_patent_app_number] => 875533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6838476 [patent_doc_number] => 20030035816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'SOLUBLE CTLA4 MUTANT MOLECULES AND USES THEREOF' [patent_app_type] => new [patent_app_number] => 09/014761 [patent_app_country] => US [patent_app_date] => 1998-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5968 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20030035816.pdf [firstpage_image] =>[orig_patent_app_number] => 09014761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1288132 [patent_doc_number] => 06632634 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-14 [patent_title] => 'Decay accelerating factor (DAF) and nucleic acid encoding it' [patent_app_type] => B1 [patent_app_number] => 09/014240 [patent_app_country] => US [patent_app_date] => 1998-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 19 [patent_no_of_words] => 14078 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/632/06632634.pdf [firstpage_image] =>[orig_patent_app_number] => 09014240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1564710 [patent_doc_number] => 06338950 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-01-15 [patent_title] => 'DNA encoding LST-1 protein and process for recombinant production of LST-1 protein' [patent_app_type] => B2 [patent_app_number] => 08/973544 [patent_app_country] => US [patent_app_date] => 1997-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5758 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/338/06338950.pdf [firstpage_image] =>[orig_patent_app_number] => 08973544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1474931 [patent_doc_number] => 06387879 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Compounds that bind growth to hormone receptor' [patent_app_type] => B1 [patent_app_number] => 08/990888 [patent_app_country] => US [patent_app_date] => 1997-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 29 [patent_no_of_words] => 11946 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387879.pdf [firstpage_image] =>[orig_patent_app_number] => 08990888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4153044 [patent_doc_number] => 06103501 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-15 [patent_title] => 'Single chain glycoprotein hormones comprising two .beta. and one .alpha. subunits and recombinant production thereof' [patent_app_type] => 1 [patent_app_number] => 8/971439 [patent_app_country] => US [patent_app_date] => 1997-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7440 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 223 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/103/06103501.pdf [firstpage_image] =>[orig_patent_app_number] => 971439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1384031 [patent_doc_number] => 06544523 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-08 [patent_title] => 'Mutant forms of Fas ligand and uses thereof' [patent_app_type] => B1 [patent_app_number] => 08/968686 [patent_app_country] => US [patent_app_date] => 1997-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24907 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/544/06544523.pdf [firstpage_image] =>[orig_patent_app_number] => 08968686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4064856 [patent_doc_number] => 05895754 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-20 [patent_title] => 'Nucleic acids encoding a truncated mouse .beta. integrin subunit' [patent_app_type] => 1 [patent_app_number] => 8/960387 [patent_app_country] => US [patent_app_date] => 1997-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 22 [patent_no_of_words] => 3775 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/895/05895754.pdf [firstpage_image] =>[orig_patent_app_number] => 960387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4140561 [patent_doc_number] => 06030808 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-29 [patent_title] => 'Nucleic acids encoding receptor recognition factor stat 3 and methods of use thereof' [patent_app_type] => 1 [patent_app_number] => 8/956869 [patent_app_country] => US [patent_app_date] => 1997-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 46615 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/030/06030808.pdf [firstpage_image] =>[orig_patent_app_number] => 956869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4196250 [patent_doc_number] => 06013475 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Nucleic acids encoding receptor recognition factors and methods of use thereof' [patent_app_type] => 1 [patent_app_number] => 8/956652 [patent_app_country] => US [patent_app_date] => 1997-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 47627 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013475.pdf [firstpage_image] =>[orig_patent_app_number] => 956652 [rel_patent_id] =>[rel_patent_doc_number] =>)